Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Rubnitz

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Blood|November 9, 2000
Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemiaA Gajjar, P L Harrison, J T Sandlund, et al.
Leukemia|June 22, 2001
Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphomaR C Ribeiro, B D Fletcher, W Kennedy, et al.
Cancer|December 18, 2001
Second malignancy after treatment of childhood non-Hodgkin lymphomaW Leung, J T Sandlund, M M Hudson, et al.
Leukemia|August 1, 1997
Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL, and ETV6 gene abnormalities: results of St Jude Total Therapy Study XIIJ E Rubnitz, F G Behm, C H Pui, et al.
Leukemia|February 26, 2004
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapseE Coustan-Smith, A Gajjar, N Hijiya, et al.
Leukemia|October 17, 2008
Clinical consequences of hyperglycemia during remission induction therapy for pediatric acute lymphoblastic leukemiaJ R Roberson, H L Spraker, J Shelso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Sex differences in prognosis for children with acute lymphoblastic leukemiaC H Pui, J M Boyett, M V Relling, et al.
Blood|October 7, 2000
Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemiaE Coustan-Smith, J Sancho, M L Hancock, et al.
Leukemia|February 12, 1999
Low frequency of TEL-AML1 in relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroupJ E Rubnitz, F G Behm, D Wichlan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2000
Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemiaM H Woo, L J Hak, M C Storm, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Blood|November 9, 2000
Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemiaA Gajjar, P L Harrison, J T Sandlund, et al.
Leukemia|June 22, 2001
Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphomaR C Ribeiro, B D Fletcher, W Kennedy, et al.
Cancer|December 18, 2001
Second malignancy after treatment of childhood non-Hodgkin lymphomaW Leung, J T Sandlund, M M Hudson, et al.
Leukemia|August 1, 1997
Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL, and ETV6 gene abnormalities: results of St Jude Total Therapy Study XIIJ E Rubnitz, F G Behm, C H Pui, et al.
Leukemia|February 26, 2004
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapseE Coustan-Smith, A Gajjar, N Hijiya, et al.
Leukemia|October 17, 2008
Clinical consequences of hyperglycemia during remission induction therapy for pediatric acute lymphoblastic leukemiaJ R Roberson, H L Spraker, J Shelso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Sex differences in prognosis for children with acute lymphoblastic leukemiaC H Pui, J M Boyett, M V Relling, et al.
Blood|October 7, 2000
Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemiaE Coustan-Smith, J Sancho, M L Hancock, et al.
Leukemia|February 12, 1999
Low frequency of TEL-AML1 in relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroupJ E Rubnitz, F G Behm, D Wichlan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2000
Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemiaM H Woo, L J Hak, M C Storm, et al.
Pageof 7